Inteva Products unveils ₹27 cr. expansion plan in Pune
The Hindu
Inteva Products expands Pune facility to meet global auto demand, plans for future growth in India.
U.S.-based automotive supplier Inteva Products on Friday announced the expansion of its production facility in Chakan, Pune to meet the rising demand of the global automobile firms.
“We are investing ₹27 crore in the Chakan plant. The expansion work has started and will get completed by next year,”Inteva Products India Automotive Pvt Ltd MD Sanjay Kataria said during an interaction.
The Chakan plant produces automotive components such as side door latches, liftgate latches, window regulators and motors for window regulators for leading Indian automakers – Tata Motors, M&M and Hyundai among others.
As per the plan, Inteva will be adding new assembly lines. It will increase the window regulator capacity to 6.3 million units.
At the same time, the production capacity of motors for window regulators will be ramped up to 9.6 million units from 8.1 million units and that of side door latches to 4.6-million units (3.4 million units).
“India is an important market for us. This expansion reflects Inteva’s ongoing commitment to the Indian market, which is important to our global growth strategy,” said Inteva Products President and CEO Gerard Roose.
He also indicated that Inteva India has started scouting for land to set up second facility as the Pune facility is full.
Equity markets decline on weak earnings, global trends; inflation hits 14-month high, foreign funds exit, oil prices rise.
Swiggy IPO debuts with a 7.69% jump at NSE, market valuation at ₹89,549.08 crore; shares listed at ₹412 on BSE.
Shares in Samsung Electronics fell on Wednesday to their lowest level in more than four years.
Mercedes-Benz India introduces the new Mercedes-AMG C 63 S E Performance sportscar with hybrid powertrain and innovative business model.
Hyundai Motor India Ltd. reports 16% profit decline in Q3 due to market sentiments, geopolitical factors, and Red Sea crisis.
Equity market plunges over 800 points, eroding market capitalisation by ₹5.29 lakh crore amid global economic concerns.
Aurobindo Pharma's CuraTeQ Biologics receives EMA GMP certificate for biosimilars, paving way for European approvals of three products.
BCCI to withdraw insolvency plea against Byju's after Supreme Court sets aside NCLAT judgement, NCLT hearing scheduled.
Natco Pharma's Q2 profits soar 83% to ₹676.5 crore, driven by robust exports and stable domestic business.
India's industrial output rebounds with 3.1% growth in September, led by manufacturing, despite weak electricity and mining sectors.
India's retail inflation hits 6.2% in October, driven by a 10.9% spike in food prices, breaching RBI's upper limit.